Medplus Health Services Ltd's subsidiary, Optival Health Solutions, received three suspension orders for drug licenses at various locations, with potential revenue losses of Rs 1.98 lacs, Rs 0.90 lacs, and Rs 0.20 lacs respectively, on March 25, 2025.